ID   CTDS1_HUMAN             Reviewed;         261 AA.
AC   Q9GZU7; C9IYG0; Q7Z5Q3; Q7Z5Q4;
DT   13-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-JUL-2015, entry version 129.
DE   RecName: Full=Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1;
DE            EC=3.1.3.16;
DE   AltName: Full=Nuclear LIM interactor-interacting factor 3;
DE            Short=NLI-IF;
DE            Short=NLI-interacting factor 3;
DE   AltName: Full=Small C-terminal domain phosphatase 1;
DE            Short=SCP1;
DE            Short=Small CTD phosphatase 1;
GN   Name=CTDSP1; Synonyms=NIF3, NLIIF, SCP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=10967134; DOI=10.1007/s003350010151;
RA   Marquet S., Lepage P., Hudson T.J., Musser J.M., Schurr E.;
RT   "Complete nucleotide sequence and genomic structure of the human
RT   NRAMP1 gene region on chromosome region 2q35.";
RL   Mamm. Genome 11:755-762(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   50-260 (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION WITH GTF2F1, AND
RP   MUTAGENESIS OF ASP-96 AND ASP-98.
RX   PubMed=12721286; DOI=10.1074/jbc.M301791200;
RA   Yeo M., Lin P.S., Dahmus M.E., Gill G.N.;
RT   "A novel RNA polymerase II C-terminal domain phosphatase that
RT   preferentially dephosphorylates serine 5.";
RL   J. Biol. Chem. 278:26078-26085(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, AND INTERACTION WITH REST.
RX   PubMed=15681389; DOI=10.1126/science.1100801;
RA   Yeo M., Lee S.-K., Lee B., Ruiz E.C., Pfaff S.L., Gill G.N.;
RT   "Small CTD phosphatases function in silencing neuronal gene
RT   expression.";
RL   Science 307:596-600(2005).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 77-261 IN COMPLEX WITH
RP   MAGNESIUM AND INHIBITOR.
RX   PubMed=15304220; DOI=10.1016/j.molcel.2004.06.035;
RA   Kamenski T., Heilmeier S., Meinhart A., Cramer P.;
RT   "Structure and mechanism of RNA polymerase II CTD phosphatases.";
RL   Mol. Cell 15:399-407(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 77-256 OF MUTANT ASN-96 IN
RP   COMPLEX WITH SUBSTRATE PEPTIDES, AND SUBSTRATE SPECIFICITY.
RX   PubMed=17157258; DOI=10.1016/j.molcel.2006.10.027;
RA   Zhang Y., Kim Y., Genoud N., Gao J., Kelly J.W., Pfaff S.L.,
RA   Gill G.N., Dixon J.E., Noel J.P.;
RT   "Determinants for dephosphorylation of the RNA polymerase II C-
RT   terminal domain by Scp1.";
RL   Mol. Cell 24:759-770(2006).
CC   -!- FUNCTION: Preferentially catalyzes the dephosphorylation of 'Ser-
CC       5' within the tandem 7 residue repeats in the C-terminal domain
CC       (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively
CC       regulates RNA polymerase II transcription, possibly by controlling
CC       the transition from initiation/capping to processive transcript
CC       elongation. Recruited by REST to neuronal genes that contain RE-1
CC       elements, leading to neuronal gene silencing in non-neuronal
CC       cells. {ECO:0000269|PubMed:12721286, ECO:0000269|PubMed:15681389}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 1 Mg(2+) ion per monomer.;
CC   -!- ENZYME REGULATION: Stimulated by GTF2F1. Inhibited by
CC       beryllofluoride anions. {ECO:0000269|PubMed:12721286}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 5. {ECO:0000269|PubMed:12721286};
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with GTF2F1. Interacts
CC       with REST. {ECO:0000250, ECO:0000269|PubMed:12721286,
CC       ECO:0000269|PubMed:15304220, ECO:0000269|PubMed:15681389,
CC       ECO:0000269|PubMed:17157258}.
CC   -!- INTERACTION:
CC       Q99618:CDCA3; NbExp=4; IntAct=EBI-751587, EBI-739534;
CC       P58466:Ctdsp1 (xeno); NbExp=2; IntAct=EBI-751587, EBI-7091612;
CC       P02686:MBP; NbExp=3; IntAct=EBI-751587, EBI-947410;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12721286}.
CC       Note=Colocalizes with RNA polymerase II.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9GZU7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9GZU7-2; Sequence=VSP_045866;
CC       Name=3;
CC         IsoId=Q9GZU7-3; Sequence=VSP_045865, VSP_045866;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expression is restricted to non-neuronal
CC       tissues. Highest expression in skeletal muscle, spleen, lung and
CC       placenta. {ECO:0000269|PubMed:15681389}.
CC   -!- SIMILARITY: Contains 1 FCP1 homology domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00336}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP34398.1; Type=Frameshift; Positions=72; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF229163; AAG15404.1; -; Genomic_DNA.
DR   EMBL; AF229162; AAG15402.1; -; mRNA.
DR   EMBL; AY279529; AAP34397.1; -; mRNA.
DR   EMBL; AY279530; AAP34398.1; ALT_FRAME; mRNA.
DR   EMBL; BX446444; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC021016; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC012977; AAH12977.1; -; mRNA.
DR   CCDS; CCDS2416.1; -. [Q9GZU7-1]
DR   CCDS; CCDS56166.1; -. [Q9GZU7-3]
DR   RefSeq; NP_001193807.1; NM_001206878.1. [Q9GZU7-3]
DR   RefSeq; NP_067021.1; NM_021198.2. [Q9GZU7-1]
DR   RefSeq; NP_872580.1; NM_182642.2. [Q9GZU7-2]
DR   UniGene; Hs.444468; -.
DR   PDB; 1T9Z; X-ray; 2.30 A; A=77-261.
DR   PDB; 1TA0; X-ray; 2.10 A; A=77-261.
DR   PDB; 2GHQ; X-ray; 2.05 A; A/B=77-256.
DR   PDB; 2GHT; X-ray; 1.80 A; A/B=77-256.
DR   PDB; 3L0B; X-ray; 2.35 A; A/B=77-256.
DR   PDB; 3L0C; X-ray; 2.45 A; A/B=77-256.
DR   PDB; 3L0Y; X-ray; 2.30 A; A/B=77-256.
DR   PDB; 3PGL; X-ray; 2.35 A; A/B=77-256.
DR   PDBsum; 1T9Z; -.
DR   PDBsum; 1TA0; -.
DR   PDBsum; 2GHQ; -.
DR   PDBsum; 2GHT; -.
DR   PDBsum; 3L0B; -.
DR   PDBsum; 3L0C; -.
DR   PDBsum; 3L0Y; -.
DR   PDBsum; 3PGL; -.
DR   ProteinModelPortal; Q9GZU7; -.
DR   SMR; Q9GZU7; 77-256.
DR   BioGrid; 121804; 15.
DR   DIP; DIP-61246N; -.
DR   IntAct; Q9GZU7; 3.
DR   MINT; MINT-1441843; -.
DR   STRING; 9606.ENSP00000273062; -.
DR   BindingDB; Q9GZU7; -.
DR   ChEMBL; CHEMBL1795098; -.
DR   DEPOD; Q9GZU7; -.
DR   PhosphoSite; Q9GZU7; -.
DR   BioMuta; CTDSP1; -.
DR   DMDM; 17865510; -.
DR   MaxQB; Q9GZU7; -.
DR   PaxDb; Q9GZU7; -.
DR   PRIDE; Q9GZU7; -.
DR   DNASU; 58190; -.
DR   Ensembl; ENST00000273062; ENSP00000273062; ENSG00000144579.
DR   Ensembl; ENST00000443891; ENSP00000392248; ENSG00000144579. [Q9GZU7-3]
DR   GeneID; 58190; -.
DR   KEGG; hsa:58190; -.
DR   UCSC; uc002vhy.3; human. [Q9GZU7-1]
DR   UCSC; uc002vhz.3; human. [Q9GZU7-2]
DR   CTD; 58190; -.
DR   GeneCards; GC02P219262; -.
DR   HGNC; HGNC:21614; CTDSP1.
DR   MIM; 605323; gene.
DR   neXtProt; NX_Q9GZU7; -.
DR   PharmGKB; PA134938848; -.
DR   eggNOG; COG5190; -.
DR   GeneTree; ENSGT00390000017194; -.
DR   HOGENOM; HOG000236379; -.
DR   HOVERGEN; HBG053298; -.
DR   InParanoid; Q9GZU7; -.
DR   KO; K15731; -.
DR   OrthoDB; EOG71P2C3; -.
DR   PhylomeDB; Q9GZU7; -.
DR   TreeFam; TF313556; -.
DR   SignaLink; Q9GZU7; -.
DR   ChiTaRS; CTDSP1; human.
DR   EvolutionaryTrace; Q9GZU7; -.
DR   GeneWiki; CTDSP1; -.
DR   GenomeRNAi; 58190; -.
DR   NextBio; 64884; -.
DR   PRO; PR:Q9GZU7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; Q9GZU7; -.
DR   CleanEx; HS_CTDSP1; -.
DR   ExpressionAtlas; Q9GZU7; baseline and differential.
DR   Genevisible; Q9GZU7; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR011948; Dullard_phosphatase.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR004274; NIF.
DR   Pfam; PF03031; NIF; 1.
DR   SMART; SM00577; CPDc; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02251; HIF-SF_euk; 1.
DR   PROSITE; PS50969; FCP1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Hydrolase; Metal-binding; Nucleus; Polymorphism; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN         1    261       Carboxy-terminal domain RNA polymerase II
FT                                polypeptide A small phosphatase 1.
FT                                /FTId=PRO_0000212572.
FT   DOMAIN       86    244       FCP1 homology. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00336}.
FT   ACT_SITE     96     96       4-aspartylphosphate intermediate.
FT   ACT_SITE     98     98       Proton donor.
FT   METAL        96     96       Magnesium. {ECO:0000269|PubMed:15304220}.
FT   METAL        98     98       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:15304220}.
FT   METAL       207    207       Magnesium. {ECO:0000269|PubMed:15304220}.
FT   SITE        152    152       Transition state stabilizer.
FT   SITE        190    190       Transition state stabilizer.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:22814378}.
FT   VAR_SEQ       1     22       MDSSAVITQISKEEARGPLRGK -> MVAAPWATQEQEEGR
FT                                GIQPGDR (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_045865.
FT   VAR_SEQ      73     73       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:12721286,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_045866.
FT   VARIANT      56     56       A -> T (in dbSNP:rs2227249).
FT                                /FTId=VAR_049054.
FT   MUTAGEN      96     96       D->E: No effect. Completely abolishes
FT                                phosphatase activity; when associated
FT                                with N-98. {ECO:0000269|PubMed:12721286}.
FT   MUTAGEN      98     98       D->N: Completely abolishes phosphatase
FT                                activity; when associated with E-96.
FT                                {ECO:0000269|PubMed:12721286}.
FT   CONFLICT    180    180       S -> F (in Ref. 3; BX446444).
FT                                {ECO:0000305}.
FT   HELIX        85     87       {ECO:0000244|PDB:2GHT}.
FT   STRAND       92     95       {ECO:0000244|PDB:2GHT}.
FT   TURN         99    101       {ECO:0000244|PDB:2GHT}.
FT   STRAND      102    107       {ECO:0000244|PDB:2GHT}.
FT   STRAND      113    120       {ECO:0000244|PDB:2GHT}.
FT   STRAND      123    131       {ECO:0000244|PDB:2GHT}.
FT   HELIX       135    145       {ECO:0000244|PDB:2GHT}.
FT   STRAND      146    151       {ECO:0000244|PDB:2GHT}.
FT   HELIX       156    166       {ECO:0000244|PDB:2GHT}.
FT   STRAND      172    176       {ECO:0000244|PDB:2GHT}.
FT   HELIX       178    180       {ECO:0000244|PDB:2GHT}.
FT   STRAND      181    184       {ECO:0000244|PDB:2GHT}.
FT   STRAND      187    189       {ECO:0000244|PDB:2GHT}.
FT   HELIX       192    194       {ECO:0000244|PDB:2GHT}.
FT   STRAND      195    197       {ECO:0000244|PDB:3L0C}.
FT   HELIX       199    201       {ECO:0000244|PDB:2GHT}.
FT   STRAND      202    205       {ECO:0000244|PDB:2GHT}.
FT   HELIX       209    212       {ECO:0000244|PDB:2GHT}.
FT   HELIX       216    218       {ECO:0000244|PDB:1TA0}.
FT   STRAND      219    221       {ECO:0000244|PDB:3L0Y}.
FT   HELIX       233    244       {ECO:0000244|PDB:2GHT}.
FT   HELIX       251    254       {ECO:0000244|PDB:2GHT}.
SQ   SEQUENCE   261 AA;  29203 MW;  75A430BCA2748FEA CRC64;
     MDSSAVITQI SKEEARGPLR GKGDQKSAAS QKPRSRGILH SLFCCVCRDD GEALPAHSGA
     PLLVEENGAI PKQTPVQYLL PEAKAQDSDK ICVVIDLDET LVHSSFKPVN NADFIIPVEI
     DGVVHQVYVL KRPHVDEFLQ RMGELFECVL FTASLAKYAD PVADLLDKWG AFRARLFRES
     CVFHRGNYVK DLSRLGRDLR RVLILDNSPA SYVFHPDNAV PVASWFDNMS DTELHDLLPF
     FEQLSRVDDV YSVLRQPRPG S
//
